Literature DB >> 25814223

Hospital length of stay and clinical outcomes in older STEMI patients after primary PCI: a report from the National Cardiovascular Data Registry.

Rajesh V Swaminathan1, Sunil V Rao2, Lisa A McCoy2, Luke K Kim3, Robert M Minutello3, S Chiu Wong3, David C Yang3, Paramita Saha-Chaudhuri4, Harsimran S Singh3, Geoffrey Bergman3, Dmitriy N Feldman3.   

Abstract

BACKGROUND: There has been a decline in hospital length of stay (LOS) after primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI).
OBJECTIVES: The objective of this study was to examine whether shorter LOS is safe for older patients undergoing PPCI for STEMI.
METHODS: The study analyzed patients' characteristics and 30-day outcomes by LOS (short, ≤3 days; medium, 4 to 5 days; long >5 days; where LOS was the discharge date minus the admission date plus 1) among 33,920 patients with STEMI in the linked CathPCI Registry-Centers for Medicare & Medicaid Services dataset who were ≥65 years of age and treated with PPCI from 2004 to 2009.
RESULTS: Percents of patients in each category were as follows: 26.9%, 46.3%, and 26.8% for short, medium, and long LOS, respectively. Patients with a long LOS were generally older, female, and had more comorbidities, including cardiogenic shock and multivessel disease. Patients with a short LOS generally had higher ejection fraction and single-vessel disease. There was no significant difference in 30-day all-cause mortality (hazard ratio [HR]: 1.00; 95% confidence interval [CI]: 0.74 to 1.34) or major adverse cardiac events (MACE) (death, readmission for myocardial infarction, unplanned revascularization: HR: 1.03; 95% CI: 0.86 to 1.25) for medium versus short LOS. There was a significant increase in adjusted mortality (HR: 2.30; 95% CI: 1.72 to 3.07) and MACE (HR: 1.75; 95% CI: 1.44 to 2.12) for long versus short LOS. Patients with a very short LOS (1 to 2 days) had significantly increased 30-day mortality and MACE compared with a 3- to 4-day LOS.
CONCLUSIONS: Patients discharged as early as 48 h after PPCI have outcomes similar to patients who stay in the hospital for 4 to 5 days. Early, but not very early (<48 h), discharge may be safe among selected older patients with STEMI.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ST-segment elevation myocardial infarction; length of stay; myocardial infarction; older patients; outcomes; primary percutaneous coronary intervention

Mesh:

Year:  2015        PMID: 25814223     DOI: 10.1016/j.jacc.2015.01.028

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

1.  Development of a Catheterization and Percutaneous Coronary Intervention Registry with a Data Management Approach: A Systematic Review.

Authors:  Alireza Tabatabaei Tabrizi; Hamid Moghaddasi; Reza Rabiei; Babak Sharif-Kashani; And Eslam Nazemi
Journal:  Perspect Health Inf Manag       Date:  2019-01-01

2.  Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention.

Authors:  Alexander C Fanaroff; Pearl Zakroysky; Daniel Wojdyla; Lisa A Kaltenbach; Matthew W Sherwood; Matthew T Roe; Tracy Y Wang; Eric D Peterson; Hitinder S Gurm; Mauricio G Cohen; John C Messenger; Sunil V Rao
Journal:  Circulation       Date:  2019-01-22       Impact factor: 29.690

3.  Early vs Late Discharge in Low-Risk ST-Elevation Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Authors:  Zain Ul Abideen Asad; Safi U Khan; Amod Amritphale; Adhir Shroff; Kusum Lata; Arnold H Seto; Muhammad Shahzeb Khan; Sunil V Rao; Mazen Abu-Fadel
Journal:  Cardiovasc Revasc Med       Date:  2020-05-01

4.  Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria.

Authors:  Elias J Dayoub; Ashwin S Nathan; Sameed Ahmed M Khatana; Rishi K Wadhera; Daniel M Kolansky; Robert W Yeh; Jay Giri; Peter W Groeneveld
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-03-15

Review 5.  Predictive model of increased mortality and bed occupancy if thrombolysis becomes the initial treatment strategy for STEMI during the SARS-CoV-2 pandemic.

Authors:  Luke Dancy; Kevin O'Gallagher; Matthew Ryan; Philip A MacCarthy; Ajay M Shah
Journal:  Clin Med (Lond)       Date:  2020-07-27       Impact factor: 2.659

6.  A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†.

Authors:  Fizzah Choudry; Stephen Hamshere; Natalie Saunders; Jessry Veerapen; Katrine Bavnbek; Charles Knight; Denis Pellerin; Didier Locca; Mark Westwood; Roby Rakhit; Tom Crake; Jens Kastrup; Mahesh Parmar; Samir Agrawal; Daniel Jones; John Martin; Anthony Mathur
Journal:  Eur Heart J       Date:  2015-09-23       Impact factor: 29.983

7.  Short Length of Stay After Elective Transfemoral Transcatheter Aortic Valve Replacement is Not Associated With Increased Early or Late Readmission Risk.

Authors:  Maneesh Sud; Feng Qui; Peter C Austin; Dennis T Ko; David Wood; Andrew Czarnecki; Vaidehi Patel; Douglas S Lee; Harindra C Wijeysundera
Journal:  J Am Heart Assoc       Date:  2017-04-24       Impact factor: 5.501

8.  Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter.

Authors:  Tarek A Hammad; Melanie Parikh; Nour Tashtish; Cynthia M Lowry; Diane Gorbey; Farshad Forouzandeh; Steven J Filby; William M Wolf; Marco A Costa; Daniel I Simon; Mehdi H Shishehbor
Journal:  Catheter Cardiovasc Interv       Date:  2020-06-01       Impact factor: 2.585

9.  ST-Segment-Elevation Myocardial Infarction Care in America: Celebration and Anxiety.

Authors:  Kirk N Garratt
Journal:  J Am Heart Assoc       Date:  2020-05-29       Impact factor: 5.501

10.  Thirty-Day Readmission Rates, Timing, Causes, and Costs after ST-Segment-Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010-2014.

Authors:  Luke K Kim; Ilhwan Yeo; Jim W Cheung; Rajesh V Swaminathan; S Chiu Wong; Konstantinos Charitakis; Oluwayemisi Adejumo; John Chae; Robert M Minutello; Geoffrey Bergman; Harsimran Singh; Dmitriy N Feldman
Journal:  J Am Heart Assoc       Date:  2018-09-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.